145 related articles for article (PubMed ID: 8630273)
1. Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
Kondo A; Maeta M; Oka A; Tsujitani S; Ikeguchi M; Kaibara N
Br J Cancer; 1996 May; 73(10):1166-70. PubMed ID: 8630273
[TBL] [Abstract][Full Text] [Related]
2. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.
Tsujitani S; Oka A; Kondo A; Katano K; Oka S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Oncology; 1999 Jul; 57(1):77-82. PubMed ID: 10394129
[TBL] [Abstract][Full Text] [Related]
3. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model.
Katano K; Tsujitani S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(6D):4547-52. PubMed ID: 9494566
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents.
Hagiwara A; Takahashi T; Kojima O; Yamaguchi T; Sasabe T; Lee M; Sakakura C; Shoubayashi S; Ikada Y; Hyon SH
Cancer; 1993 Feb; 71(3):844-50. PubMed ID: 8431867
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
[TBL] [Abstract][Full Text] [Related]
7. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules.
Yamashita K; Tsunoda S; Gunji S; Murakami T; Suzuki T; Tabata Y; Sakai Y
Surg Today; 2019 Sep; 49(9):785-794. PubMed ID: 30847629
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice.
Tamura T; Fujita F; Tanimoto M; Koike M; Suzuki A; Fujita M; Horikiri Y; Sakamoto Y; Suzuki T; Yoshino H
J Control Release; 2002 Apr; 80(1-3):295-307. PubMed ID: 11943406
[TBL] [Abstract][Full Text] [Related]
10. The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer.
Tsujitani S; Fukuda K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Surgery; 2002 Jan; 131(1 Suppl):S98-104. PubMed ID: 11821794
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
[TBL] [Abstract][Full Text] [Related]
12. Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres.
Kumagai S; Sugiyama T; Nishida T; Ushijima K; Yakushiji M
Jpn J Cancer Res; 1996 Apr; 87(4):412-7. PubMed ID: 8641974
[TBL] [Abstract][Full Text] [Related]
13. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.
Pestieau SR; Schnake KJ; Stuart OA; Sugarbaker PH
Cancer Chemother Pharmacol; 2001 Mar; 47(3):269-76. PubMed ID: 11320672
[TBL] [Abstract][Full Text] [Related]
14. [The inhibitory effect of intraperitoneal hyperthermic and hypotonic chemotherapy on ascites cancer cells in mice].
Chen Z; Peng D; Tan J
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):101-4. PubMed ID: 7657323
[TBL] [Abstract][Full Text] [Related]
15. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
Los G; Mutsaers PH; Ruevekamp M; McVie JG
Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
[TBL] [Abstract][Full Text] [Related]
16. Hypotonic stress enhances colon cancer cell death induced by platinum derivatives and immunologically improves antitumor efficacy of intraperitoneal chemotherapy.
Demontoux L; Derangère V; Pilot T; Thinselin C; Chevriaux A; Chalmin F; Bouyer F; Ghiringhelli F; Rébé C
Int J Cancer; 2019 Dec; 145(11):3101-3111. PubMed ID: 31344262
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of cisplatin incorporated into polylactic acid microcapsules.
Araki H; Tani T; Kodama M
Artif Organs; 1999 Feb; 23(2):161-8. PubMed ID: 10027886
[TBL] [Abstract][Full Text] [Related]
18. Design and testing of a new cisplatin form using a base material by combining poly-D,L-lactic acid and polyethylene glycol acid against peritoneal metastasis.
Tokuda K; Natsugoe S; Shimada M; Kumanohoso T; Baba M; Takao S; Nakamura K; Yamada K; Yoshizawa H; Hatate Y; Aikou T
Int J Cancer; 1998 May; 76(5):709-12. PubMed ID: 9610730
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
[TBL] [Abstract][Full Text] [Related]
20. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.
Elias D; El Otmany A; Bonnay M; Paci A; Ducreux M; Antoun S; Lasser P; Laurent S; Bourget P
Oncology; 2002; 63(4):346-52. PubMed ID: 12417789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
